Sign In
Buy OVID
$2.44
-0.0100 (-0.408%)
At Close: Jul 17, 2026
Il produttore svedese di farmaci, Novartis (SWX: NOVN), ha detto la scorsa settimana che non chiederà più l’approvazione europea per lo Xiidra (farmaco contro la secchezza oculare). Secondo Takeda
Takeda estimates £162.50 million hit to operating loss as Novartis withdraws from European approval for Xiidra | Invezz
02:25pm, Monday, 29'th Jun 2020
Swedish drugmaker, Novartis (SWX: NOVN), said last week that it will no longer seek European approval for Xiidra (dry-eye drug). According to Takeda Pharmaceutical (TYO: 4502), Novartis decision is ex
Ovid Therapeutics Added to Russell 2000® and Russell 3000® Indexes
12:00pm, Monday, 29'th Jun 2020
NEW YORK, June 29, 2020 -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare.
Voloridge Investment Management LLC Decreases Stake in Takeda Pharmaceutical Co Ltd (NYSE:TAK)
10:06am, Sunday, 28'th Jun 2020
Voloridge Investment Management LLC lessened its stake in Takeda Pharmaceutical Co Ltd (NYSE:TAK) by 78.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 77,572 s
The 1 Company Most Likely to Derail Teladoc Health | The Motley Fool
11:11am, Saturday, 27'th Jun 2020
This giant isn't exactly a sleeping one.
Takeda India donates Rs 1.2 cr to PM CARES Fund
07:31am, Friday, 26'th Jun 2020
The contribution to the Fund aims to support patients and the government to contain the spread of the disease, the company said in a statement. "Takeda remains committed to standing together and supp
Translate Bio : Announces Pricing of Public Offering of Common Stock | MarketScreener
01:36am, Friday, 26'th Jun 2020What is antibody treatment and how can it help in coronavirus fight?
12:00am, Friday, 26'th Jun 2020
Your source for credible news and authoritative insights from Hong Kong, China and the world.
Okta, CrowdStrike, Netskope, and Proofpoint Join Together to Secure Remote Work | | IT Business Net
09:01pm, Thursday, 25'th Jun 2020
Companies to deliver integrated product solutions, advanced insights, and reference architectures to seamlessly implement a comprehensive security strategy SAN FRANCISCO & SUNNYVALE, Calif. &
5 of the Best Pharmaceutical Stocks to Buy Right Now
01:05pm, Thursday, 25'th Jun 2020
A handful of pharmaceutical stocks have been on fire these days, but I'm writing for a "buy" prescription for five of the best names now.
Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%
12:58pm, Thursday, 25'th Jun 2020
Ovid Therapeutics (OVID) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
Enterome Closes €46.3M Financing Round | FinSMEs
08:59am, Thursday, 25'th Jun 2020
Enterome SA, a Paris, France-based clinical-stage biopharmaceutical company leveraging its knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, raised €46.3m
6 Stocks That Could Edge Higher
12:00am, Thursday, 25'th Jun 2020
Stocks Analysis by Harry Boxer covering: Kamada, Allied Healthcare Products Inc, Dynavax Technologies Corporation, Lakeland Industries Inc. Read Harry Boxer's latest article on Investing.com
Head to Head Analysis: Ovid Therapeutics (NASDAQ:OVID) & Cotinga Pharmaceuticals (NASDAQ:COTQF)
01:36am, Wednesday, 24'th Jun 2020
Ovid Therapeutics (NASDAQ:OVID) and Cotinga Pharmaceuticals (OTCMKTS:COTQF) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength
Xconomy: Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease
09:04pm, Tuesday, 23'rd Jun 2020
Reneo Pharmaceuticals has encouraging results from an early trial of a compound it is advancing for rare diseases characterized by impaired
